Bacterial metabolite indole modulates incretin secretion from intestinal enteroendocrine L cells.

Chimerel C, Emery E, Summers DK, Keyser U, Gribble FM, Reimann F. · 2014

Read Bacterial metabolite indole modulates incretin secretion from intestinal enteroendocrine L cells. by Chimerel C, Emery E, Summers DK, Keyser U, Gribble FM, Reimann F. (2014) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4308618.txt.

Introduction

Catalin Chimerel, Edward Emery, David K Summers, Ulrich Keyser, Fiona M Gribble, and Frank Reimann found that indole, a chemical made by gut bacteria, steers hormone release from gut L cells. Their study appeared in Cell Reports in 2014. L cells release GLP-1, a hormone that helps control blood sugar, and bacterial products were long suspected of influencing that release.

Indole had two opposite effects split by time. Brief contact boosted GLP-1 output by widening the cell's electrical pulses and letting in more calcium. Longer contact slowed the cell's energy production and cut release. The double action makes indole a true signal between gut microbes and host metabolism, with possible bearing on diabetes research.

Catalog record

CREATORChimerel C, Emery E, Summers DK, Keyser U, Gribble FM, Reimann F.
YEAR2014
COLLECTIONPAPERS
FORMATTXT
FILE SIZE40 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4308618

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Bacterial Metabolite Indole Modulates Incretin Secretion from Intestinal Enteroendocrine L Cells By Catalin Chimerel, Edward Emery, David K Summers, Ulrich Keyser, Fiona M Gribble, Frank Reimann Published in: Cell Reports DOI: 10.1016/j.celrep.2014.10.032 ABSTRACT Summary It has long been speculated that metabolites, produced by gut microbiota, influence host metabolism in health and diseases. Here, we reveal that indole, a metabolite produced from the dissimilation of tryptophan, is able to modulate the secretion of glucagon-like peptide-1 (GLP-1) from immortalized and primary mouse colonic L cells. Indole increased GLP-1 release during short exposures, but it reduced secretion over longer periods. These effects were attributed to the ability of indole to affect two key molecular mechanisms in L cells. On the one hand, indole inhibited voltage-gated K+ channels, increased the temporal width of action potentials fired by L cells, and led to enhanced Ca2+ entry, thereby acutely stimulating GLP-1 secretion. On the other hand, indole slowed ATP production by blocking NADH dehydrogenase, thus leading to a prolonged reduction of GLP-1 secretion. Our results identify indole as a signaling molecule by which gut microbiota communicate with L cells and influence host metabolism. INTRODUCTION Obesity is one of the biggest health and socioeconomic issues of the 21st century, with the number of obese individuals worldwide almost doubling within the last 30 years. People suffering from obesity are at high risk of developing other metabolic diseases such as type 2 diabetes mellitus (T2DM), cardiovascular disease, and nonalcoholic fatty liver disease (Nicholson et al., 2012). Increasing physical activity and reducing food intake are recommended when treating obesity and associated metabolic diseases, but outcomes are only moderately successful as such lifestyle changes are not sustained long-term by most patients. Alternative strategies therefore need to be developed in order to control body weight more effectively. Anorectic gut hormones such as glucagon-like peptide 1 (GLP-1) and peptide YY are secreted into the circulatory system by enteroendocrine L cells in response to changes in the content of the gut lumen and are at the frontline of the search for new therapies. Gut hormones play essential roles in a wide range of metabolic functions such as the regulation of food absorption, appetite, and glucose homeostasis. As a consequence, drugs that enhance GLP-1 action are now widely used in the treatment of T2DM (Garber et al., 2009, Nauck et al., 2009, Zinman et al., 2009) and are under investigation for the treatment of obesity (Marre et al., 2009). Attention is also turning toward the enteroendocrine L cells themselves and whether they could be targeted for the treatment of obesity and diabetes. Enteroendocrine L cells are distributed along the length of the intestinal epithelium and thus make direct contact with the gut microbiota. The colon not only harbors the highest density of enteroendocrine L cells within the intestine, but it is also host to the largest number of bacteria. Although it is widely believed that gut microbiota can modulate the function of colonic L cells, our understanding of the molecular mechanisms underlying this potential crosstalk is limited (Cani et al., 2013, Devaraj et al., 2013). Among the metabolites produced by bacteria in the gut, recent attention has focused on short-chain fatty acids, produced by the fermentation of unabsorbed starch and nonstarch polysaccharides. Short chain fatty acids activate G protein coupled receptors (GPCRs) expressed on the plasma membrane of L cells, enhancing L cell number and secretion (Cani et al., 2013, Petersen et al., 2014, Plaisancié et al., 1995, Psichas et al., 2014, Tarini and Wolever, 2010, Tolhurst et al., 2012). Many other bacterial metabolites are also abundantly present within the luminal contents of the colon (Nyangale et al., 2012). Here we focused on a metabolite of tryptophan, indole, as it has recently been shown that plasma tryptophan concentrations are decreased in mice following Roux-en-Y gastric bypass surgery (Mutch et al., 2009) and elevated in people with a high risk of developing T2DM (Wang et al., 2011). Moreover, indole production has been shown previously to vary with the dietary tryptophan content in human subjects (Bryan, 1966). Indole, the most prevalent metabolite of tryptophan, is produced by a wide range of bacterial species, including those belonging to the genera Escherichia, Bacteroides, and Clostridium (DeMoss and Moser, 1969, Lee and Lee, 2010, Smith and Macfarlane, 1996). These bacterial species use tryptophanase to degrade tryptophan into indole, pyruvate, and ammonia, which leads to an average indole concentration ranging from 0.25 to 1.2 mM in human faeces (Karlin et al., 1985, Zuccato et al., 1993). Indole has been previously identified as a beneficial signaling molecule involved in crosstalk between the microbiota and gut wall by increasing epithelial cell tight junctions and attenuating indicators of inflammation (Bansal et al., 2010). Here we show that the bacterial signal indole modulates GLP-1 secretion from enteroendocrine cells, and we identify the molecular mechanisms underlying this interaction. RESULTS Indole Modulates GLP-1 Secretion from GLUTag Cells Cumulative GLP-1 secretion from GLUTag cells was measured in the presence of saline buffer containing 1 mM glucose and 0.1% (wt/vol) BSA over 240 min (Figure 1A). The GLP-1 concentration in the medium increased approximately linearly with time under these conditions, reflecting a relatively constant GLP-1 secretory rate (Figure 1B). In the additional presence of 1 mM indole, GLP-1 secretion was modified over both short and long time periods. Very high GLP-1 concentrations were measured in the medium of indole-treated cells after only 5 min, indicating a rapid initial stimulation of secretion (Figures 1A and 1B). Thereafter, GLP-1 concentrations continued to rise, but the rate of release was slower than that observed in the absence of indole (Figure 1B). At the end of the 240 min incubation period, cumulative released GLP-1 was ∼35% less in the presence of 1 mM indole than in its absence. These data indicate that although indole acutely stimulates GLP-1 secretion, it exerts a suppressive effect on the rate of hormone release over prolonged time periods. We examined the dose dependence of indole on both the short- and long-term actions by measuring cumulative GLP-1 release after 6 and 240 min incubations (Figures 1C and 1D). After 6 min, the acute stimulatory effect of indole was evident at concentrations above 1 mM. After 240 min, by contrast, the suppressive effect was evident at indole concentrations as low as 0.3 mM. To clarify the interaction between indole and GLUTag cells, we investigated the molecular mechanisms that determine the modulation of GLP-1 secretion by indole. [Figure: Modulation of GLP-1 Secretion in GLUTag Cells by Indole(A) Cumulative GLP-1 secretion from GLUTag cells stimulated with 1 mM glucose, measured at different time points. Cells were incubated with and without 1 mM indole, and secretion was normalized to the 60 min, 1 mM glucose, time point (average value of 15 pg/ml) from the same experiment. Each data point was calculated by averaging over eight or more independent measurements. Significance was calculated at specific time points comparing the secretion at 1 mM glucose and the secretion at 1 mM glucose + 1 mM indole.(B) Calculated rates of GLP-1 secretion over the time periods indicated, calculated from the data in (A). a.u., arbitrary units.(C) GLP-1 secretion measured in response to different indole concentrations for an incubation time of 6 min in the presence of

Read the complete text